JP Morgan Maintains Overweight on Qiagen, Raises Price Target to $60

QIAGEN NV -1.26%

QIAGEN NV

QGEN

40.60

-1.26%

JP Morgan analyst Casey Woodring maintains Qiagen (NYSE: QGEN) with a Overweight and raises the price target from $55 to $60.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via